The Hemodynamic Monitoring Systems Market Staggering Double Digit Cagr Driven By Advanced & Cost Effective Technologies Forecasts Till 2023

 Hemodynamic Monitoring Systems Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

Hemodynamic Monitoring Systems Market Research Report by Product (Disposables, Monitors, Minimally Invasive, Others), Type (Invasive, Non-invasive, Others), End-user (Hospitals, Clinics, Ambulatory Care Centers, Home Care Settings, Others), and Region-Global forecast till 2023 – Global Industry Analysis By Size, Share, Trends, Business opportunities and Challenges.

Hemodynamic Monitoring Systems Market Overview

Based on the careful analysis of the latest trends, Market Research Future (MRFR) reports that the global hemodynamic monitoring systems market will be achieving the valuation of USD 1,054 million by the end of 2023, expanding at a CAGR of almost 7.3% during the forecast period (2018-2023). The market worth was USD 780 Million in 2017, indicating a lucrative growth pattern backed by numerous factors.

Also Read : https://www.medgadget.com/2020/01/hemodynamic-monitoring-systems-market-size-market-growth-investment-share-competitive-analysis-industry-highlights-identify-opportunities-and-challenges-with-usd-780-million-by-forecast-to-2023.html 

Market Drivers and Key Restraints

In the past couple of years, the hemodynamic monitoring systems market worldwide has showcased a dramatic growth primarily due to an alarming rise in the prevalence of cardiovascular diseases, coupled with various health conditions brought on by sedentary lifestyles and the increasing need for critical congenital heart disease (CCHD) screening. Also, the surging incidence of COPD and other respiratory disorders will also bring in good news for the market in the years to come.

On that note, the impact of these factors on the growth of the market is expected to be amplified on account of the highly conducive regulatory scenario currently existing. Furthermore, a rapidly graying world population is resulting in the surging adoption of hemodynamic monitoring systems in healthcare centers around the globe.

In addition, neonatal care professionals’ dependency on hemodynamic monitoring systems has grown in recent years, with CCHD being considered as one among the seven most life-threatening congenital heart defects. Similarly, COPD has elevated to unprecedented levels amongst adults, particularly in low- and middle-income countries.

Hemodynamic Monitoring Systems Market Segmentation

The market for hemodynamic monitoring systems is segmented on the basis of product, type, and end-use.

The market, depending on the product, caters to disposables, monitors, minimally invasive, and others. Out of these, the monitors segment is leading the pack, account for the largest share in the global market.

Type-wise, the market is considered for invasive, non-invasive, and others. The invasive segment accounts for the largest among all the types.

The end-user industries in the global market are hospitals, clinics, ambulatory care centers, home care settings, and others.  Hospitals and clinics make for the largest segment, out of all the segments in the global market.

Hemodynamic Monitoring Systems Market Regional Outlook

The regions among which the Hemodynamic Monitoring Systems Market is spread across include the Americas, Asia Pacific, the Middle East & Africa and Europe. Out of all the regions, the Americas dominate the global market, with Asia Pacific touted to be the fastest growing region.

The regional market of hemodynamic monitoring systems in the Americas is expanding at a significant pace owing to various factors. These factors include the rapid uptake of advanced technologies in the well-established healthcare sector as well as the high per capita health care expenditures in the region.  Furthermore, the growing prevalence of diabetes and hypertension, in addition to the increasing use of patient monitoring systems and a massive base of renowned device manufacturers in Canada and the United States (US) contribute to the growth of the regional market as well.

On the other hand, the market in Asia Pacific is benefitting largely due to the expanding geriatric population coupled with the growing prevalence of high/low BP, hypertension, cardiovascular diseases, as well as obesity issues that lead to heart diseases & disorders. Apart from this, few other dominant factors like the rapid adoption of healthcare technology, favorable insurance, reimbursement policies and government initiatives to improve the quality of healthcare are also fostering the market growth in the region.

Moreover, MRFR acknowledges Europe as the second-largest hemodynamic monitoring systems market, at a global level.  The regional market has been profiting predominantly on the back of the increasing healthcare expenditure, government initiatives and availability of advanced treatment facilities. Additionally, the surging cardiovascular issues causing concerns will be highly instrumental in the market growth in the coming years.

Hemodynamic Monitoring Systems Market Studied by Top Players

The companies currently holding the leading position in the global hemodynamic monitoring systems market include Osypka Medical, CNSystems, PULSION Medical Systems SE, Teleflex Incorporated, Argon Medica, Cheetah Medical, Deltex Medical Group Plc., ICU Medical, Osypka Medical GmbH, Edwards Lifesciences Corporation; CareTaker Medical, LiDCO Group plc, NI Medical, and Uscom.

Mergers & acquisitions, innovation, product launch, and expansion are few strategies adopted by these players in a bid to maintain their positions in the competitive market.

For instance, in March 2019, reports say that Edwards Lifesciences will be acquiring CAS Medical Systems (CASMED), which is a medical technology company with expertise in non-invasive monitoring of tissue oxygenation in the brain, for the sum of about USD 100 million. Edwards Lifesciences will be receiving 510(k) clearance for a smart cable and software module that allows compatibility between HemoSphere, a hemodynamic monitoring platform and CASMED’s FORE-SIGHT sensor.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hemodynamic-monitoring-systems-market-6678 

Medical Pendant Market Innovative Treatments, Key Methodologies, Size, Growth, Top Players Success Milestones And Forecasts To 2023

 Medical Pendant Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Medical Pendant Market Analysis

Global medical pendant market is expected to exhibit a solid 7% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global medical pendant market is expected to grow from a valuation of USD 95.18 million to USD 149.01 million by the end of 2023. The report provides a detailed overview of the global medical pendant market, including a review of the major drivers and restraints affecting the global market. The impact of the COVID-19 pandemic on the global medical pendant market is also assessed in the report.

Also Read : https://www.medgadget.com/2020/08/covid-19-outbreak-impact-on-medical-pendant-market-size-2020-industry-size-share-swot-analysis-technology-advancement-business-growth-opportunities.html

 

Medical pendants are wireless devices that alert healthcare professionals if the wearer has an attack of certain diseases. The increasing adoption of advanced technology in the healthcare sector is the major driver for the global medical pendant market. Medical pendants are among the most advanced medical technologies available to man, as they combine medical diagnostic capabilities with the wireless communication technology needed to alert healthcare professionals. The adoption of high-grade wireless communication technology around the world is a major driver for the global medical pendant market. Instant alerting is essential to the functioning of medical pendants, as medical care needs to reach the patient immediately in case of certain diseases such as heart attacks and stroke. The adoption of advanced wireless communication protocols around the world is thus likely to remain a major driver for the global medical pendant market over the forecast period.

On the other hand, the high cost of medical pendants is the major restraint against the global medical pendant market. Especially in emerging countries, the high cost of medical implants has held the market back, as most consumers cannot afford the high costs of medical pendants. Emerging technological upgrades and the increasing achievement of an economy of scale by medical pendant manufacturers are likely to bring the costs of medical pendants down in the coming years. This is likely to lead to increasing demand from the medical pendant market over the forecast period.

Medical Pendant Market Competitive Leaderboard:

Leading players in the global medical pendant market include BeaconMedaes, Surgiris, Starkstrom, Brandon Medical Co. Ltd., Tedisel Medical, Medimax Korea Co. Ltd., Elektra Hellas SA, Megasan Medikal, Ondal Medical Systems GmbH, and Skytron LLC. Major players in the global medical pendant market are likely to engage in technological innovation in the coming years, in order to come up with solutions that are easier to fit on humans and cheaper to boot.

Medical Pendant Market Segmentation:

The global medical pendant market is segmented based on product, application, and region.

By product, the global medical pendant market is segmented into fixed pendants, fixed retractable pendants, single arm movable pendants, double and multi-arm movable pendants, and accessories. Fixed pendants hold the largest share in the global medical pendant market due to their convenience and their older development, which has led to widespread adoption. The single arm movable pendants segment accounts for the highest growth rate among all product segments of the medical pendant market.

By application, the global medical pendant market is segmented into hospital, clinics, and others. The hospital segment is further sub-segmented into intensive care unit (ICU), operating theater (OT) and recovery room (RR), and emergency room (ER). The clinics segment is the fastest growing segment of the global medical pendant market.

Medical Pendant Market Regional Analysis:

North America is the largest regional market for medical pendants and is likely to dominate the global market over the forecast period. The high healthcare expenditure in North America is the prime driver for the medical pendant market in the region. The high disposable income of patients in the region is also a crucial driver for the medical pendant market, as high amounts of investment is needed to install a medical pendant.

Asia Pacific is the fastest growing regional market for medical pendants. Growing awareness about medical pendants is likely to be a major driver for the medical pendant market in Asia Pacific over the forecast period.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/medical-pendant-market-6681 

World Abetalipoproteinemia Monitoring Systems Market Estimation Of Top Key Players Shares, Revenue, Analysis And Forecasts Till 2023

 Abetalipoproteinemia Monitoring Systems Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Abetalipoproteinemia Monitoring Systems Market -Overview:

Health reflects the lifestyle one leads and the sounder the health, the better lifestyle. However, with rapid urbanization and fast-tracked industrialization, physiological anomalies have become a recurring occurrence. Abetalipoproteinemia is an offshoot of such tendency where the disorder interferes in the regular absorption process of fat and fat-soluble vitamins from food. It is a result of a mutation in microsomal triglyceride transfer protein which affects the gastrointestinal system, eyes, nervous system, and blood circulation. That is why its monitoring has become imperative giving rise to the abetalipoproteinemia monitoring systems market.

Also Read : https://www.medgadget.com/2018/12/abetalipoproteinemia-monitoring-systems-market-by-clinical-review-new-professional-adaptations-technology-analysis-and-synthesis-2018-to-2023.html 

The global abetalipoproteinemia monitoring systems market, at present, is expecting a hike by 9.8% CAGR during the forecast period (2018-2023) which can set its market valuation at USD 147 million by 2023, claims Market Research Future (MRFR).

Industry Updates:

March 21, 2018: Designed for seniors, TruSense, a smart home monitoring solution, has recently announced that it has added its first-ever smart personal emergency response pendant which combine GPS with notification when it is not being worn, thus extending protection even when outside the home. TruSense GPS Smart Pendant works in combination with TruSense Home. The combination offers customized alerts whenever the pendant is not being worn, thereby eradicating all the false sense of security created.

Abetalipoproteinemia Monitoring Systems Market – Segmentation:

By diagnosis, the abetalipoproteinemia monitoring systems market can be segmented into molecular genetic testing and blood testing, of which molecular genetic testing is expected to grow with the fastest CAGR during the forecast period.

Based on blood testing treatment, the abetalipoproteinemia monitoring systems market includes fat-soluble vitamins supplementation and others. Fat-soluble vitamins supplementation is spearheading the abetalipoproteinemia monitoring systems market.

Based on end-user, the abetalipoproteinemia monitoring systems market can be segmented into hospitals & clinics, diagnostics lab, and others. Hospitals & clinics segment is dominating the market with substantial market revenue.

Abetalipoproteinemia Monitoring Systems Market – Key Competitors:

Prominent market influencers to spur the growth of the abetalipoproteinemia monitoring systems market are Lonza, Piramal Pharma Solutions, Abbott Laboratories, Koninklijke DSM N.V., and Barrington Nutritionals.

Abetalipoproteinemia Monitoring Systems Market – Regional Analysis:

Geographic analysis of the abetalipoproteinemia monitoring systems market includes the Americas, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).

The Americas market can be further segmented into North and South America. Superior healthcare system and advancement in research & development in the field have boosted the market prospect in the region. However, its rare sighting is a market deterrent.

Europe shares similar features like that of North America. The region banks on the technological brilliance of countries such as Germany, France, Italy, Spain, and the U.K. The APAC has Japan, China, and India as major contributors. But the developing regions in both the MEA and the APAC may bring forward more cases of abetalipoproteinemia as one of the main influencers of this disease is malnutrition and both the regions have several countries with a large population affected by malnutrition.

Global Abetalipoproteinemia Monitoring Systems Market by Region

• The Americas
• Europe
• Asia Pacific
• Middle East & Africa

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/abetalipoproteinemia-monitoring-systems-market-6683 

Diagnostic Imaging Market Will Generate An Enormous Revenue Till 2023| Market Research Future

 Recently MRFR, a leading market research firm collated a novel report on “Global Diagnostic Imaging Market Research Study” that gives comprehensive market overview about the current market dynamics with a focus on the worldwide market.

The Global Diagnostic Imaging Market is expected to grow during the forecast period (2018–2023) at a CAGR ~6.2%. Global Diagnostic Imaging Market: Information by Product Type (X-Ray Equipment, Ultrasound Imaging Systems, and Others), Application (Gynecology, Oncology, Orthopedics, and Others ), End-User (Hospitals and clinics, and Others)—Global Forecast till 2023

Also Read : https://www.medgadget.com/2019/04/diagnostic-imaging-market-demand-insights-by-recent-trends-size-share-estimation-by-top-players-growth-analysis-key-developments-and-forecast-by-2023.html 

Key Players :

Market Research Future (MRFR) recognizes the following companies as the key players in Diagnostic Imaging Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of the key players in the global diagnostic imaging market are Siemens Healthcare Private Limited, Koninklijke Philips N.V.,CANON MEDICAL SYSTEMS CORPORATION, Shimadzu Corporation, Carestream Health,Esoate SpA, GE Healthcare, Toshiba Medical Systems Corporation,FUJIFILM Holdings Corporation, Hitachi Medical Systems, and Hologic Inc.

Market Drivers :

Diagnostic imaging helps to understand the functioning of body parts and create visual representation of interior of the body and provides support in detection of medical disorder. The continues increase in geriatric population, increasing prevalence of chronic diseases, and technological advancements are the major factors driving the growth of the global diagnostic imaging market. Additionally, increasing investment in R&D and aggressive strategies adopted by the major players, such as new product launches along with merger and acquisitions, are contributing to the growth of the market. For instance, in March 2017, General Electric Company announced the acquisition of Monica healthcare  for undisclosed amount, with this transaction the company will gain control over 1000 sites of Monica healthcare across Europe, Asia and north America .

The high costs associated with diagnostic imaging devices, unfavorable reimbursement policies and scarcity of technicians are likely to hinder market growth during the forecast period.

Segments :

The global diagnostic imaging market has been segmented on the basis of product, source, and application.

Based on  product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other products

The market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applications

The end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.

Regional Analysis :

The Americas are likely to dominate the global diagnostic imaging market owing to the rising prevalence of chronic diseases in the aging population, increase in the number of cancer patients, the presence of a well-established healthcare system, and adoption of highly advanced technology. According to National cancer institute, in 2016, 15.5 million cancer cases were registered in united states, and it is expected to reach 20.3 million by the end of 2016. Also, the expenditure on cancer care in 2017 was 147.3 billion.

The European market is expected to be the second-largest diagnostic imaging market. The market growth in this region can be attributed to the favorable regulatory policies, increasing number of hospitals and diagnostic centers, and increasing healthcare expenditure. Moreover, increasing cases of chronic disorders is contributing to the growth of the market in this region. According to the Organization for Economic Co-operation and Development, in 2016 chronic diseases such as heart attacks, strokes, diabetes and cancer were responsible for 550,000 premature deaths in Europe and it cost around USD 130 billion to the economy.

Asia-Pacific is expected to be the fastest-growing diagnostic imaging market during the forecast period owing to the rising prevalence of chronic diseases, increasing  investments in healthcare and expansions by market players in the region, and increase in disposable income.

The market in the Middle East & Africa is expected to account for the smallest share of the global diagnostic imaging market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/diagnostic-imaging-market-6765 

Liquid Handling System 2020 Global Market Key Players, Analysis and Forecast to 2023

 Market Scenario

Global liquid handling equipment market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 2.95 billion in 2017 and is projected to grow at a CAGR of 8.7% over the forecast period. The liquid handling system is a laboratory instrument system consisting of tools and equipment designed to execute mixing, sampling, and combining of liquid samples. The factors such as an increase in investments in drug development, growing demand for high-output screening, growing expenditure on research & development (R&D), and rising adoption of automation in clinical settings are expected to drive the market growth over the forecast period. According to the World Bank, in the US, the research and development expenditure (as % of Gross Domestic Product) was 2.79% in 2015.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6588 

Despite the drivers, the high cost associated with the liquid handling systems and complex operability of the latest liquid handling systems is anticipated to restrain the growth of the market over the assessment period.

Segmentation

The global liquid handling system market has been segmented into type, product, application, and end-user.

The market, on the basis of type, has been segmented into manual, automated, and electronic liquid handling system. The electronic liquid handling system segment is expected to hold major market share in 2017 owing to the high accuracy and reproducibility offered by the electronic liquid handling system.

The market on the basis of product has been segmented into pipettes, consumables, microplate reagent dispensers, liquid handling workstations, burettes, software, and others. The pipette segment has been segmented into manual pipettes, electronic pipettes, and semi-automated pipettes. The consumables segment has been segmented into disposable tips, tubes and plates, reagent containers, and others.

The global market, by application, has been segmented into drug discovery, genomics, clinical diagnostics, proteomics, and others. The drug discovery segment has been segmented into ADME screening, high-throughput screening (HTS), compound weighing and dissolution, and others. The genomics segment has been segmented into genotyping, next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA/RNA purification, and others. The clinical diagnostics segment has been segmented into sample preparation, ELISA, and others.

The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, contract research organizations (CRO), and others.

The global liquid handling system market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The liquid handling system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European liquid handling system market has been segmented into Western Europe and Eastern Europe. Western Europe has further been segmented as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The liquid handling system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The liquid handling system market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific, Inc., Eppendorf AG, Tecan Group Ltd., Bio-Rad Laboratories, Corning Incorporated, Sartorius AG, Hamilton Company, Mettler-Toledo International Inc., and Perkinelmer, Inc. are some of the key players in the global liquid handling system market.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/liquid-handling-system-market-6588 

Healthcare Claims Management Market to Perceive Momentous Accruals with a hefty CAGR By 2023

 Market Scenario

Global healthcare claims management market is expected to grow significantly over the forecast period. It is estimated that the global healthcare claims management market is expected to register a CAGR ~ 5.37% during the forecast period of 2018–2023. Healthcare claims management process comprises of various tasks such as organization, billing, filling, updating, and processing of medical claims related to the diagnosis, treatment, and medication of patients.

The global market is driven by factors such as increase in ageing population, rise in incidence of chronic diseases, improved focus on healthcare quality services and advent of innovative treatments & technologies.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6376 

Factors such as increasing concerns regarding the patient data safety and security limit and data breaches and loss of confidentiality, lack of skilled IT professionals in healthcare are restraining the growth of medical claims management solutions market. According to the National Health Insurer Report Card published in 2011 by American Medical Association (AMA), around $17 billion a year (on an average) could be saved by eliminating errors in claims.

Segmentation

The global healthcare claims management solutions market has been segmented into component, delivery mode type and end-user. The market, based on component, has been segmented into software and services. The market, by delivery mode, has been segmented into on-premise and cloud based. The market, by type, has been segmented into integrated and standalone. The market, by end-user has been segmented into healthcare payers and providers.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The healthcare claims management market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European healthcare claims management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The healthcare claims management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The healthcare claims management market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Cerner Corporation (US), McKesson Corporation (US), Athenahealth (US), eClinicalWorks (US), Optum, Inc. (US), Conifer Health Solutions (US), nThrive (US), Avaya Inc. (USA), Oracle Corporation (US), Infor Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Accenture plc. (Ireland), IBM Corporation (US), Cognizant Technology Solutions Corporation (US) and Genpact Limited (US) are some of the key players in the global healthcare claims management market.

Regional Market Summary

Geographically, the Americas is expected to dominate the global healthcare claims management market due to the growing HCIT investments in the region and the presence of regulatory mandates favouring the implementation of healthcare claims management solutions.

Europe is expected to hold the second largest position in the global healthcare claims management market. The market growth in this region is because of the rise in prevalence of chronic diseases, presence of well-established healthcare system and increase in insurance coverage.

Asia-Pacific is estimated to be the fastest growing region in the market due to the improved healthcare infrastructure and increasing geriatric population.

On the other hand, the Middle East & Africa has the least share of the market. This is due to low technological advancements in the field of healthcare IT.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/healthcare-claims-management-market-6376 

Medical Bionic Implant Market to Perceive Momentous Accruals with a hefty CAGR By 2023

 Market Scenario

The global medical bionic implant market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the medical bionic implant market is expected to register a CAGR of 7.0% during the forecast period of 2018–2023.

Bionic implants are artificially engineered devices that are implanted into a human to replace a natural organ. The main purpose of bionic implants is to provide life support to prevent imminent death while awaiting a transplant and improve a patient's ability to interact socially.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6051 

It is observed that the increasing cases of organ failure have increased the demand for replaceable organs, which is propelling the medical bionic implant/artificial organs market to a great extent. According to the statistics suggested by the National Kidney Foundation, 2016  around 121,678 people were waiting for lifesaving organ transplants in the in the United States. It is also reported that in 2014, 17,107 kidney transplants took place in the U.S. The incidences of organ failure are found to be more common in the aging population, as it is more vulnerable towards health issues such as ophthalmic diseases, gastrointestinal problems, orthopedic diseases, cancer, and others.

Various other factors such as technological advancements, increasing accidents and injuries, improving regulatory framework, increasing government assistance, and increasing prevalence of eye diseases are continuously contributing to the growth of the global medical bionic implant/artificial organs market.

Despite these drivers, there are some issues associated with the medical bionic implant/artificial organs market. Lack of skilled professionals, the high cost of devices, fear of malfunction of devices, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.

Regional Market Summary

The Americas dominates the medical bionic implant/artificial organs market owing to the introduction of advanced medical bionic implants by major market players. On November 02, 2017, Second Sight Medical Products, Inc., a U.S. based company, received the U.S. FDA approval to initiate the Orion Cortical Visual Prosthesis System (Orion) feasibility clinical study. In 2013, the company won the FDA approval for the Argus II retinal prosthesis system.

Europe holds the second position in the medical bionic implant/artificial organs market. It is expected that the government support towards research and development expenditure and increasing cases of organ failure and related complications are likely to drive the European market.

Asia Pacific is the fastest growing medical bionic implant/artificial organs market owing to a huge patient pool, increasing demand for advanced treatments, and development in the healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions. According to the data suggested by Australian Institute of Health and Welfare during the year 2015 to 2016, the total health expenditure was USD 170.4 billion, i.e., 3.6% higher than the expenditure during 2014 to 2015.

The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Key Players

Some of key the players in the global medical bionic implant/artificial organs  market are Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.).

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/medical-bionic-implant-artificial-organs-market-6051